Correlation between abnormal cytological findings and human papillomavirus infection of the uterine cervix in Bulgarian women

References

• IARC Working Group on the Evaluation of Carcinogenic Risk to Humans . Human papillomaviruses. Vol. 90, IARC monographs on the evaluation of carcinogenic risks to humans. Lyon : International Agency for Research on Cancer; 2007. Chapter 1, Human papillomavirus (HPV) infection. Available from: http://www.ncbi.nlm.nih.gov/books/NBK321770/
   Google Scholar
• Koss LG , Durfee GR . Cytological changes preceding the appearance of in situ carcinoma of the uterine cervix. Cancer. 1955;8:295–301.
   PubMed Web of Science ®Google Scholar
• Della Torre G , Pilotti S , De Palo G , et al. Viral particles in cervical condylomatous lesions. Tumori. 1978;64:549–553.
   PubMed Web of Science ®Google Scholar
• Meisels A , Fortin R . Condylomatous lesions of the cervix and vagina. I. Cytological patterns. Acta Cytol. 1976;20:505–509.
   PubMed Web of Science ®Google Scholar
• Purola E , Savia E . Cytology of gynecologic condyloma acuminatum. Acta Cytol. 1977;21:26–31.
   PubMed Web of Science ®Google Scholar
• Fischer S , Bettstetter M , Becher A , et al. Shift in prevalence of HPV types in cervical cytology specimens in the era of HPV vaccination. Oncol Lett. 2016;12(1):601–610.
   PubMed Web of Science ®Google Scholar
• Rijkaart DC , Heideman DA , Coupe VM , et al. High-risk human papillomavirus (hrHPV) E6/E7 mRNA testing by PreTect HPV-Proofer for detection of cervical high-grade intraepithelial neoplasia and cancer among hrHPV DNA-positive women with normal cytology. J Clin Microbiol. 2012;50(7):2390–2396.
   PubMed Web of Science ®Google Scholar
• Bauer HM , Ting Y , Greer CE , et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA. 1991;265:472–477.
   PubMed Web of Science ®Google Scholar
• Rozendaal L , Westerga J , van der Linden JC , et al. PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changes. J Clin Pathol. 2000;53:606–611.
   PubMed Web of Science ®Google Scholar
• Kovachev S , Slavov V . Causative relations between human papilloma virus infection and cervical intraepithelial neoplasia. Biotechnol Biotechnol Equip. 2016;30(3):558–561.
   Web of Science ®Google Scholar
• Michalas SP. The Pap test: George N. Papanicolaou (1883–1962). a screening test for the prevention of cancer of uterine cervix. Eur J Obstet Gynecol Reprod Biol. 2000;90:135–138.
   PubMed Web of Science ®Google Scholar
• Solomon D , Davey D , Kurman R , et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287:2114–2119.
   PubMed Web of Science ®Google Scholar
• Herrington S . The pathogenesis of cervical neoplasia. In: Gray W , McKee GT , editors. Diagnostic cytopathology. London: Churchill Livingstone; 2003. p. 707–753.
   Google Scholar
• Richardson LA , El-Zein M , Ramanakumar AV , et al. PEACHS (Pap Efficacy After Cervical HPV Status) Study Consortium. HPV DNA testing with cytology triage in cervical cancer screening: influence of revealing HPV infection status. Cancer Cytopathol. 2015;123(12):745–754.
   PubMed Web of Science ®Google Scholar
• Méndez Toro L , Rodríguez Meza A , López de Sánchez M , et al. [HPV infection associated with nonclassic cytological signs in patients from Mérida, Venezuela]. Invest Clin. 2011;52(2):162–169. Spanish.
   PubMed Web of Science ®Google Scholar
• Lee SH , Vigliotti JS , Vigliotti VS , et al. From human papillomavirus (HPV) detection to cervical cancer prevention in clinical practice. Cancers (Basel). 201 4;6(4):2072–2099.
   PubMed Web of Science ®Google Scholar
• Stout NK , Goldhaber-Fiebert JD , Ortendahl JD , et al. Trade-offs in cervical cancer prevention: balancing benefits and risks. Arch Intern Med. 2008;168:1881–1889. doi: 10.1001/archinte.168.17.1881.
   PubMedGoogle Scholar
• Bruni L , Diaz M , Castellsague M , et al. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202(12):1789–1799.
   PubMed Web of Science ®Google Scholar
• Rosa M , Mohammadi A . Cervical cytology and human papillomavirus testing in adolescent women: implications in management of a positive HPV test. Patholog Res Int [Internet]. 2014 [cited 2016 Feb 7];165690. Available from: http://www.hindawi.com/journals/pri/2014/165690/
   PubMedGoogle Scholar
• Arbyn M , Roelens J , Simoens C , et al. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions. Cochrane Database Syst Rev. 2013;3:CD008054. doi: 10.1002/14651858.CD008054.pub2.
   Google Scholar
• Food and Drug Administration . FDA approves first human papillomavirus test for primary cervical cancer screening. Silver Spring (MD): U.S. Food and Drug Administration [updated 2014 Apr 24; cited 2016 Jul 30]. Available from: http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm394773.htm
   Google Scholar
• Silva-Caso W , Olivera-Irazábal M , León-Álvarez P , et al. Identification of human papillomavirus as a preventive strategy for cervical cancer in asymptomatic women in the Peruvian Andes. Asian Pac J Trop Med. 2014;7(S1):S121–126.
   Web of Science ®Google Scholar
• Min KJ , Lee YJ , Suh M , et al. The Korean guideline for cervical cancer screening. J Korean Med Assoc. 2015;58(5):398–407.
   Web of Science ®Google Scholar